Full name
PHARMA CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.14.Z - Agents involved in the sale of machinery, industrial equipment, ships and aircraft
33.2 - Installation of industrial machinery and equipment and outfit
46.1 - Wholesale on a fee or contract basis
46.6 - Wholesale of other machinery, equipment and supplies
46.7 - Other specialised wholesale
46.9 - Non-specialised wholesale trade
47.99.Z - Other retail sale not in stores, stalls or markets
70.2 - Management consultancy activities
71.2 - Technical testing and analysis
74.1 - Specialised design activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,3 | 0,4 | 0,4 | -11,4 |
EBITDA | -0,3 | 0,4 | 0,4 | -11,5 |
Short time liabilities | 0,3 | 0,3 | 0,5 | 79,5 |
Equity capital | 0,1 | 0,2 | 0,6 | 152,2 |
Operating profit (EBIT) | -0,3 | 0,4 | 0,4 | -11,5 |
Assets | 0,4 | 0,5 | 1,1 | 112,9 |
Net profit (loss) | -0,3 | 0,4 | 0,4 | -12,1 |
Cash | 0,1 | 0 | 0 | -53,3 |
Liabilities and provisions for liabilities | 0,3 | 0,3 | 0,5 | 79,5 |
Net income from sale | 2,2 | 3 | 3,2 | 6,9 |
Working assets | 0,4 | 0,5 | 1,1 | 112,9 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -519,9 | 173,1 | 60,3 | -112,8 |
Equity capital to total assets | 18,1 | 46 | 54,5 | 8,5 |
Gross profit margin | -15,5 | 14,3 | 11,8 | -2,5 |
EBITDA Margin | -15,4 | 14,3 | 11,8 | -2,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 49 | 35 | 59 | 24 |
Current financial liquidity indicator | 1.2206476926803589 | 1.8513725996017456 | 2.1962459087371826 | 0,3 |
Net dept to EBITDA | -0.4691942036151886 | 0.4007231295108795 | 0.5147668719291687 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane